Seeing Is Believing
Currently out of the existing stock ratings of Kelly Shi, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).
Analyst Kelly Shi works at JEFFERIES with a stock forecast success ratio of 45.24% fulfilled within 195.43 days on average.
Kelly Shi’s has documented 36 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACET, Adicet Bio at 05-Jan-2024.
Analyst best performing recommendations are on MLTX (MOONLAKE IMMUNOTHERAPEUTICS).
The best stock recommendation documented was for MLTX (MOONLAKE IMMUNOTHERAPEUTICS) at 6/26/2023. The price target of $58 was fulfilled within 22 days with a profit of $12.05 (26.22%) receiving and performance score of 11.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
0.5
$0.5 (0.00%)
0.5
1 years 1 months 3 days ago
1/4 (25%)
$0.36 (257.14%)
2
Hold
0.15
$0.15 (0.00%)
2
1 years 3 months 25 days ago
1/4 (25%)
$-0.01 (-6.25%)
8
Buy
19
$18.86 (13471.43%)
19
2 years 4 months 3 days ago
0/5 (0%)
$14.39 (153.53%)
Sell
21
2 years 7 months 27 days ago
2/2 (100%)
$0.83 (4.65%)
18
Buy
30
$29.99 (299900.00%)
30
2 years 8 months 12 days ago
0/2 (0%)
$11.69 (64.34%)
Which stock is Kelly Shi is most bullish on?
Which stock is Kelly Shi is most reserved on?
What Year was the first public recommendation made by Kelly Shi?